![James Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Brady
Direktör/Styrelseledamot på
XERIS BIOPHARMA HOLDINGS, INC.
Förmögenhet: 698 291 $ per 2026-05-31
Profil
James Brady is an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. since 2025.
Former roles include Director at Panavance Therapeutics, Inc. from 2021 to 2025, Independent Non-Executive Director at Verona Pharma Ltd. from 2022 to 2025, Chief Financial Officer at MedImmune Ltd. from 2013 to 2018, and Chief Audit Executive at AstraZeneca PLC from 2009 to 2012.
Education includes an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-04 | 113 359 ( 0,07 % ) | 698 291 $ | 2026-05-31 |
Aktiva positioner av James Brady
| Företag | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direktör/Styrelseledamot | 2025-03-28 |
Tidigare kända positioner av James Brady
| Företag | Position | Slut |
|---|---|---|
| VERONA PHARMA PLC | Direktör/Styrelseledamot | 2025-10-07 |
Panavance Therapeutics, Inc.
 Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direktör/Styrelseledamot | 2025-02-01 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Finansdirektör/CFO | 2018-01-01 |
| ASTRAZENECA PLC | Comptroller/Controller/Revisor | 2012-01-01 |
James Bradys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
St. Joseph University
 St. Joseph University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Panavance Therapeutics, Inc.
Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
